FDA Inspection
Frontida Biopharm, LLCFrontida Biopharm, LLC – FDA Inspection, Oct 24, 2025
Record Details
This FDA Inspection record concerns Frontida Biopharm, LLC, with an inspection on October 24, 2025, issued by the Chicago District Office, covering human drugs.
View Company Profile
ID · e7bdf618-1f6a-4a66-b243-95bdbeb8f6c8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1283762
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.100(b)SOPs not followed / documented
- 21 CFR 211.22(a)Lack of quality control unit
- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Frontida Biopharm, LLC
5| Date | Classification | Office | Project area |
|---|---|---|---|
| February 26, 2021 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 18, 2016 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| February 26, 2013 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 16, 2011 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 5, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Frontida Biopharm, LLC
- FDA Inspection 1137467 - 2021-02-26
- FDA Inspection 961359 - 2016-02-18
- FDA Inspection 820917 - 2013-02-26
- FDA Inspection 739828 - 2011-08-16
- FDA Inspection 637304 - 2010-01-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.